Skip to main content
Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Risk Factors for Sporadic Non-Pregnancy Associated Listeriosis in Germany—Immunocompromised Patients and Frequently Consumed Ready-To-Eat Products

  • Karina Preußel ,

    Affiliation Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany

  • Astrid Milde-Busch,

    Affiliation Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany

  • Patrick Schmich,

    Affiliation Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany

  • Matthias Wetzstein,

    Affiliation Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany

  • Klaus Stark,

    Affiliation Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany

  • Dirk Werber

    Current Address: Berlin Unit for Infectious Disease Surveillance and Environmental Health, State Office for Health and Social Affairs, Berlin, Germany

    Affiliation Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany


27 Oct 2016: The PLOS ONE Staff (2016) Correction: Risk Factors for Sporadic Non-Pregnancy Associated Listeriosis in Germany—Immunocompromised Patients and Frequently Consumed Ready-To-Eat Products. PLOS ONE 11(10): e0165990. View correction


Non-pregnancy associated (N-PA) listeriosis, caused by Listeria monocytogenes, is a rare but severe disease, and is predominantly food-borne. Most cases appear sporadic and their infection vehicle remains unknown. Incidence has increased since 2008 in Germany. We aimed to identify underlying conditions and foods associated with sporadic N-PA listeriosis in Germany. We performed a nationwide case-control study from March 2012-December 2013. Cases were sporadic N-PA listeriosis patients notified to public health. Control subjects were age (40–65 years, 66–75 years, ≥76 years) frequency-matched persons from a nationwide random telephone sample. A structured questionnaire collected information on underlying diseases, therapies and >60 food items. We conducted multivariable logistic regression analysis, adjusting for host factors identified by causal diagram theory, and calculated population attributable fractions. We enrolled 109 cases and 1982 controls. Cases’ median age was 69 years, 55% were male, 44% received immunosuppressive therapy within 3 months prior to illness onset; a further 28% had at least one immunocompromising disease. In multivariable analysis, immunosuppressive therapy (OR 8.8, 95%CI 4.9–15.6), immunocompromising disease (OR 2.7; 95%CI 1.4–5.2), gastric acid suppression (OR 3.0; 95%CI 1.4–6.3), the consumption of cold cooked sausages (OR 2.6; 95%CI 1.6–4.4), the preferred consumption of packaged cheese (OR 2.1; 95%CI 1.3–3.5) and pre-sliced cheese (OR 2.2; 95%CI 1.3–3.7) were significantly associated with N-PA listeriosis. These foods accounted for 59% of all cases. Typical high risk foods, e.g. cold seafood, certain types of cheeses, tended to be negatively associated with disease. In conclusion, immunosuppressive therapy and frequently consumed ready-to-eat foods are the main risk factors for sporadic N-PA listeriosis in Germany. To reduce their risk, immunocompromised persons should consume the identified foods well before the ‘use-by’ date. The microbiological criteria for Listeria monocytogenes in ready-to-eat foods may insufficiently protect persons who are markedly immunocompromised.


Listeriosis is a rare but life-threatening disease with high mortality, caused by the bacterium Listeria monocytogenes. Host factors relating to reduced immunocompetency are known to play an important role in listeriosis. Cases occur predominantly in the elderly and in immunocompromised persons (non-pregnancy associated, ‘N-PA’), and in pregnant women. Moreover, gastric acid suppression increases susceptibility to bacterial enteric infection [1], but an association with listeriosis independent of underlying diseases has not been demonstrated thus far. In adults, common manifestations of listeriosis are meningoencephalitis, sepsis and focal infections in various organ systems.

L. monocytogenes is transmitted predominantly through contaminated food [2]. Various food vehicles have been identified in outbreaks [35] including ready-to-eat meat products (e.g. frankfurters), pasteurized and unpasteurized cheese (e.g. soft cheeses), fruit, vegetables and fish products. Case-control studies of risk factors for sporadic illness have produced highly inconsistent results. One failed to identify food items at all [6], others found statistical associations with different foods that could often explained only a minority of the cases [79], including hummus and ice milk [9], ready-to-eat beef, smoked fish, prawns, milk, butter, cheese and mixed salads [7, 10]. The importance of these foods or other risk factors for sporadic N-PA listeriosis in Germany has not been systematically investigated so far.

In Germany, detection of L. monocytogenes in cultures from a normally sterile site, usually from blood or cerebrospinal fluid, is notifiable to the local Public health department. Most notified cases appear sporadic, are N-PA (>90%), and the source of infection remains unknown. Listeriosis is associated with the highest mortality (7–9% of notified cases, 2009–2013) and years of potential life lost among classical notifiable enteric pathogens [11], even when neglecting the contribution of pregnancy associated cases. Annual incidence of notified N-PA listeriosis has increased from 0.3 per 100 000 population in 2008 to 0.5 per 100 000 population in 2013. We aimed to identify underlying conditions and foods associated with N-PA listeriosis.


Study Design and Data Collection

We conducted an age frequency-matched case-control study in all German Federal States, except for the Federal city state of Bremen (0.8% of the German population), and enrolled cases prospectively from 15 March 2012 (Baden-Württemberg: 29 May 2012) to 31 December 2013. A case was defined as clinically compatible illness (fever, septicaemia, meningitis or localized organ infection) in a non-pregnant person with isolation of L. monocytogenes from a normally sterile site who was notified to a local health department during the study period, but not part of a recognized outbreak for which a common vehicle of infection was identified.

Staff from local health authorities contacted case patients to request informed verbal consent and documented patients’ response. Obtaining written informed consent was deemed to be associated with substantial time delay, thereby reducing patients’ food history recall, particularly as most patients were still in hospital when contacted by telephone. Consent procedure was approved by the ethics committee.

Case interviews were conducted by staff from the local health authorities or the Robert Koch Institute (RKI). If a case patient was too ill or deceased, proxy interviews with persons familiar with the patient’s food history or dietary habits were attempted.

Population-based control subjects were nationwide identified by random sampling of telephone numbers continuously between March 2012 and October 2013. The sample was generated by the GESIS Leibniz Institute for Social Sciences, Mannheim according to the method by Gabler and Häder [12], taking into account telephone numbers not registered in telephone books. Computer-assisted telephone interviews (CATI) were conducted by the RKI targeting the oldest member of the household. To ensure balanced completion of control-strata, enrollment was split in blocks of 35 persons, i.e. recruitment was interrupted in a stratum after enrollment of 35 participants until the other strata had reached an equal number of enrolled control-subjects. Eligible control subjects had no known history of listeriosis and had to be accessible by telephone in Germany. Control subjects were frequency-matched by age-categories (40–65 years, 66–75 years, ≥76 years), which represented the terciles of the age distribution of reported N-PA-cases between 2004 and 2011. We attempted to recruit four controls per case (n = 400) to be able to identify associations with an odds ratio (OR) of 1.45 as statistically significant (1-β = 0.9; α = 0.05).

The structured questionnaire collected information on socio-demographic characteristics, symptoms of illness (only for cases), knowledge of the disease and transmission routes for listeriosis, underlying diseases, medication, and >60 items of food consumption and purchase during the 4-weeks prior to symptom onset (for cases) or prior to the interview (for controls). Information on underlying conditions was elicited for a) diseases accompanied with reduced immunocompetency and b) immunosuppressive therapies in the 3 months prior to illness onset (cases) or to interview (controls). For a list of conditions see Table 1.

Table 1. Association* of underlying conditions with non-pregnancy associated listeriosis in in a case control study in Germany, 2012–2013.

Data from case patients was entered into an EpiData database (version 3.1, The EpiData Association, Denmark) and validated by double data entry. Data from controls were extracted from the CATI database (Voxco, Montreal, Canada) and merged with case data.

Data Analysis

Information for the person’s highest educational background was classified as “high” (polytechnic or university degree), “medium” (apprenticeship or [advanced] vocational education), or “low” (no or current training) and used as an indicator for socioeconomic status (SES) [13]. Type of residence was classified as “village” (<2000 inhabitants), “town” (2000–100 000 inhabitants) or “metropolis” (>100 000 inhabitants), according to the definition of Germany’s Federal Statistical Office. Food exposure data, which were collected in four frequency categories (from “never” to “daily”) were dichotomized. Additionally, we combined various types of cheese that had a negative association with N-PA listeriosis (p<0.05) into a single variable that represented the consumption of at least one negatively associated type of cheese.

The case population was described with respect to frequencies of socio-demographic characteristics, underlying conditions and main disease outcomes.

Cases with information elicited from proxies were excluded from analysis of previous knowledge about listeriosis. Furthermore, knowledge about listeriosis and disease transmission in the study population was investigated with respect to underlying conditions.

Univariable analysis was performed for host variables and for all food related exposure variables. We computed univariable OR and 95% confidence intervals (95% CI) using logistic regression, adjusted for the matching factor age-category. Underlying conditions significantly associated with N-PA listeriosis and known to be associated with reduced immunocompetency [1418] were grouped into “immunosuppressive therapy in the 3 months prior to illness onset (case) or interview (controls)”, e.g. chemotherapy, and “immunocompromising diseases” without immunosuppressive therapy, e.g. diabetes. These categories were mutually exclusive and were compared against “no relevant condition”, i.e. none of the conditions included in the former categories (see Table 1). Gastric acid suppression was considered as separate host factor, since we assumed that gastric acid suppression increases susceptibility to enteric infections primarily by non-immunologic mechanisms, thus distancing it from the mechanisms of immunocompromising diseases and therapies.

Multivariable logistic regression modeling was used with the primary objective of investigating the independent relationship of single food-exposures and N-PA listeriosis, while adjusting for the potential confounding effect of host factors. Thereafter, we applied a-two step strategy. First, we constructed directed acyclic graphs (‘causal diagrams’) to visualize the hypothesized causal structure of host factors and N-PA listeriosis. The relationships displayed in the graph were based on statistical associations identified in epidemiological, clinical and nutritional studies, official statistics, or, if the former was lacking, plausible assumptions (Fig 1). Because analytical adjustment for potential confounding variables can create bias where none exist [19], we deduced the minimally sufficient adjustment set to minimize bias using the graphical interface DAGitty [20]. Second, we then employed a manual forward stepwise selection strategy with the forced-in variables of the minimally sufficient adjustment set and food-items as candidate variables that had a p-value <0.05 in univariable analysis. Variables for points of food purchase and supply were not considered for multivariable modelling because of too many missing values. We set the p-value for candidate variables eligible for multivariable modeling narrowly to p<0.05 to reduce the risk of increasing bias and model non-convergence due to too few outcome events per explanatory variable [21]. Main-effects of the final multivariable logistic regression model were investigated for statistical interactions using the likelihood-ratio test. Model specification was assessed with the link test.

Fig 1. Hypothesized causal structure of exposure, host factors and non-pregnancy associated listeriosis, Germany, 2012–2013 [4861].

* Proxy for socio-economic status

Presumed causal relationships based on:

Significant associations in scientific studies

1 Age-related changes of the immune system (immunosenescence) lead to increased susceptibility to infections [48] in general; risk for listeriosis increases with age [49]

2 Prevalence of chronic health conditions in Germany increases with age [50]

3 Dietary behavior of German adults depends on age [51, 52]

5 Socioeconomic status depends on age in a highly representative sample of the German population [13]

8 Presence of an underlying immunocompromising disease or therapy increases risk for listeriosis [24, 25]

9 Experimental evidence suggests increased susceptibility for listeriosis in male animals [53]

10 Socioeconomic status depends on sex in a highly representative sample of the German population [13]

11 Dietary patterns among German adults differ between the sexes [51]

13 Socioeconomic status influences nutrition pattern [54]

14 Health (morbidity) is related to socioeconomic status in highly representative samples of the German population [55]

18 Morbidity is related to sex in highly representative samples of the German population [50]

19 Prescription of gastric acid suppressors is related to sex in Germany [56]

21 Prescription of gastric acid suppressors is related to age in Germany [56]

23 Prevalence of reflux symptoms (indication for gastric acid suppression) is significantly associated to socioeconomic status in a highly representative sample of the German population [57]; chronic use of gastric acid suppressors is associated with low income and low educational level [58]

24 Gastric acid suppression lowered infectious dose of L. monocytogenes in animals [59] and was associated with listeriosis outbreak [60]

Official Statistics:

17 Residence determines access to retailers, food handlers, farmer's markets etc. (; last accessed on 18.12.2014)


4 Knowledge about listeriosis depends on age (e.g. by lifelong learning, age-dependent access to electronic media)

6 People with underlying disease are better informed about listeriosis through physicians or self-study

7 Consumption pattern of people with underlying immunocompromising diseases or therapy differ from those of healthy people (food intolerances, special diets etc.)

12 People with higher SES (educational background) are better informed about listeriosis

15 SES influences choice of residence

16 Susceptible persons who know listeriosis tend to avoid consumption of risk foods

20 Consumption pattern of people with gastric acid suppression differ from those of people without (weight loss diet is recommended as non-drug treatment for reflux diseases in German treatment guidelines)

22 High level of (inappropriate) prescriptions of gastric acid suppressors for hospitalized patients are continued in primary care [61]

Population attributable fractions for risk factors in the final multivariable model were estimated with 95% CI based on the method described by Greenland and Drescher [22, 23].

All statistical analyses were performed using Stata/IC 12.1 (StataCorp LP, USA).

Ethics Statement

Ethics approval was obtained from the Ethics committee of the Charité, Berlin (EA2/067/11) and the Federal Medical Association of Baden Württemberg (B-F-2012-038). Data collection and storage procedures were approved by the Federal Commissioner for Data Protection and Freedom of Information.


We enrolled 109 case-patients out of 733 (15%) notified listeriosis patients (Fig 2) with a median age of 69 years (interquartile range, IQR 60–76); 60 (55%) were male. 103 (94%) case patients were hospitalized and four (4%) died. One-third (34%) of the case patients developed meningitis (n = 37) and 20 (18%) developed sepsis. Sepsis was reported more frequently in cases older than 65 years compared to those who were younger (22% vs. 12%; χ2 p = 0.17).

Fig 2. Enrollment of non-pregnancy associated listeriosis cases.

Cases included in the study were similar to notified cases not included with respect to sex, regional distribution of residence and proportion of sepsis. They were somewhat younger (median age: 69 years vs. 73 years; Wilcoxon rank-sum p = 0.02) and a higher proportion developed meningitis than those not included in the study (32% vs. 21%; χ2 p = 0.01). Confirmed listeriosis related death was 2.5-times more frequently reported for cases not included in the study (10%; χ2 p = 0.03).

75 (72%) case patients reported at least one of the underlying diseases or immunosuppressive therapies associated with listeriosis (Table 1). Immunosuppressive therapies in the 3 months prior to illness onset were mentioned by 46 (44%) case patients, particularly in cases aged ≤65 years (n = 23 [58%] vs. n = 23 [36%] in cases >65 years; χ2 p = 0.03).

During the study period, no listeriosis outbreak with evidence for a food vehicle was identified in Germany. The National Reference Center for Salmonella and other bacterial enteric pathogens did not find evidence of outbreaks by subtyping isolates voluntarily submitted for outbreak surveillance Likewise, the statistical algorithms of the RKI did not flag a significant increase of listeriosis notifications during the time period.

Of 1990 recruited controls, eight had to be excluded due to their statement that they had suffered from listeriosis previously, resulting in 1982 control persons that were included in the study. Controls did not differ from cases with respect to age, sex and type of residence (Table 2), but had a higher proportion of high-level qualification than cases (33%; cases: 21%; χ2 p = 0.01). A higher proportion of control persons knew about listeriosis (33%) than case patients prior to their illness (20%).

Table 2. Demographic characteristics of the study population in a case control study of risk factors for non-pregnancy associated listeriosis in Germany, 2012–2013.

Knowledge about the disease was low in persons with immunocompromising diseases or who had received immunosuppressive therapy: only 13% of cases (7/54) and 10% of controls (58/589; χ2 p = 0.47) knew transmission risks of listeriosis. Transmission via food was least known among persons under radiation therapy in the preceeding 3 months (1/21; 5%).

In univariable analysis, several underlying conditions were positively associated with listeriosis, including diabetes, renal disease or chemotherapy within the last 3 months as well as gastric acid suppression (Table 1). Furthermore, the following food-related exposures were significantly associated with increased odds of listeriosis (p<0.05): consumption of cold cooked sausages, pre-sliced cheese, packaged cheese, raw fermented spreadable sausages, cheese purchased in a supermarket or discounter, foods consumed in a hospital or nursing home, and foods consumed in a restaurant or canteen at least once a weak. We found 23 exposures negatively associated with listeriosis (Table 3).

Table 3. Food exposures statistically significantly associated with non-pregnancy associated listeriosis, Germany, 2012–2013: age-adjusted univariable logistic regression analysis.

Based on the causal diagram (Fig 1), we identified age, sex, immunocompromising disease or immunosuppressive therapy, and gastric acid suppression as a minimally sufficient adjustment set, which was forced into the multivariable model (Table 4). Immunosuppressive therapies and immunocompromising diseases remained strongly associated with listeriosis in the multivariable model. The odds of listeriosis in persons who had received immunosuppressive therapy in the last 3 months was approximately 9 times that of persons without any immunocompromising conditions (OR 8.75, 95% CI 4.91–15.58) and almost 3 times that of persons with immunocompromising diseases but without immunosuppressive therapy (OR 2.74, 95% CI 1.44–5.20). Furthermore, gastric acid suppression raised the odds for listeriosis by factor 3 (OR 2.96, 95% CI 1.40–6.25). The consumption of cold cooked sausages and preferred consumption of packaged cheese and sliced cheese were significantly associated with N-PA listeriosis.

Table 4. Risk factors for sporadic non-pregnancy associated listeriosis in Germany, 2012–2013: multivariable logistic regression analysis.

The model specification was confirmed by the link test. We did not find significant interactions between the model variables.

The population attributable fraction (PAF) of the food-variables, i.e. consumption of non-reheated cold cooked sausages, preferably packaged cheese or preferably sliced cheese was approximately 25% each (Table 4). The total PAF for all identified risk foods was 58.9% (95% CI 49.8%–66.4%).


This population-based case-control study of risk factors for sporadic N-PA listeriosis in Germany yielded three main findings. First, reduced immunocompetency is the major risk factor for listeriosis. Second, foods associated with listeriosis, i.e. cold cooked sausages and both packaged cheese and pre-sliced cheese, are ready-to-eat, usually have a long shelf-life, and were popular among the general adult population in Germany. Together, they accounted for 59% of the cases in Germany. Third, about 80% of cases had never heard of listeriosis prior to their illness and only 6% of the immunocompromised control population knew about the principally foodborne nature of the disease, indicating an as yet under-utilized potential for risk communication and disease prevention.

Our study confirmed [2426] and quantified the outstanding role of reduced immunocompetency for development of N-PA listeriosis. 44% of cases had received an immunosuppressive therapy within the 3 months prior to illness onset and another 28% had an underlying immunocompromising disease, such as diabetes. The disease risk appeared to correlate with degree of reduced immunocompetency (assuming that patients who recently received immunosuppressive therapy were, on average, more immunocompromised than those with “only” immunocompromising disease(s)). Moreover, knowledge about listeriosis transmission pathways was low among immunocompromised persons and appeared to be particularly lacking among persons who had received chemotherapy or radiation therapy within the last 3 months. To our knowledge, dietary recommendations for prevention of food-borne infections do not exist for this subgroup of patients in Germany. Hence, healthcare institutions in Germany should be aware of the increased risk of immunocompromised persons for listeriosis if catering food for this population.

Gastric acid suppression was associated with listeriosis in former studies [79, 26] but failed to be an independent risk factor when controlled for underlying immunocompromising conditions [6, 27]. In our study, gastric acid suppression remained associated with listeriosis when adjusted for immunocompromising diseases and immunosuppressive therapy. Yet, all cases with gastric acid suppression and complete information for underlying conditions (n = 16) suffered also from at least one underlying immunocompromising disease (n = 7) or had received immunosuppressive therapy (n = 9). Thus, use of these drugs warrants particular care in already immunocompromised persons.

The identified ready-to-eat foods in this study, which are all frequently consumed in Germany, have not yet been considered risky foods in Germany, but they are plausible vehicles for sporadic N-PA listeriosis. Cold cooked sausages are heated during manufacturing but they are susceptible to post-production contamination until package [28]. They also support relatively rapid growth of L. monocytogenes under refrigerated storage conditions [29, 30] and L. monoctyogenes is frequently detected in these products [31]. Furthermore, our finding of a significant association between listeriosis and consumption of cold cooked sausages that were not reheated before eating are consistent with a quantitative risk assessment of foodborne L. monocytogenes among ready-to-eat foods [32] in which non reheated frankfurters (a cold cooked sausage), were classified as a (very) high risk food.

Many different types of cheese–made of unpasteurized milk as well as from pasteurized milk–were identified as vehicle in listeriosis outbreaks [33] or have been the subject of an alert within the European Commission-operated Rapid Alert System for Food and Feed because of contamination with L. monocytogenes [34]. In keeping with this, we identified no single type of cheese but two retail forms of cheese, irrespective of the cheese type, that were statistically significantly associated with listeriosis. “Packaged cheese”combined various types of soft, semi-hard or hard cheese sold as whole pieces as well as pre-sliced. Notably, packaged cheese for self-service normally has an extended shelf-life and supports the growth of L. monocytogenes [35] after possible post-production contamination [36]. In contrast, cheese bought at counters is frequently cross-contaminated with mold and therefore has a shorter durability [37]. Hard cheese is the top-selling type of cheese in Germany and is often consumer-friendly offered as pre-sliced product, particularly in self-service retail, which accounts for 93% of cheese sales [38]. Slicing equipment is a known source for Listeria contamination in the food production and processing environment [39, 40]. Low level contamination of sliced cheese products with L. monocytogenes is not unusual [41] and sometimes even sufficient to cause outbreaks [42]. In our study, 18% of the control population reported daily consumption of sliced cheeses, a further 54% at least once per week. The popularity of pre-sliced and hard cheese in the general population may outweigh the apparently low prevalence of L. monocytogenes in hard cheese (0.4%), seldom in high concentrations (approx. 14% of positive samples), in a recent food survey in Germany [43].

The ability of L. monocytogenes to grow at low temperatures is well known [44]. Therefore, the European Commission Regulation on microbiological criteria for foodstuffs (EC No 2073/2005) requires that the concentration of L. monoytogenes in ready-to-eat foods, such as cold cooked sausages or pre-sliced and packaged cheeses, does not exceed 100 colony forming units per gram throughout the shelf-life. Our study results indicate (i) that this safety level may be insufficient to protect immunocompromised persons from acquiring listeriosis or (ii) that these ready-to-eat foods were consumed after the ‘use by’ date or the minimum durability date, thereby allowing L. monocytogenes to multiply to concentrations above the safety level, or both. That the retail form (e.g. pre-sliced/packaged) rather than a specific cheese type appeared to be important in this study, coupled with the observation that L. monocytogenes is infrequently present in these cheeses, lends credibility to the hypothesis that the time-interval between production and consumption of these cheeses, and possibly also of cold cooked sausages, plays a pivotal role for acquiring N-PA listeriosis in Germany. By eliminating the risk associated with any one of these foods, 25% of cases in Germany could be prevented (and 59% by eliminating the risk of all three) indicating their relevance for listeriosis in Germany and the large disease prevention potential.

Similar to other case-control studies of risk factors for sporadic listeriosis [6, 9], our study did not find a statistical association of listeriosis with many typical high risk foods, such as ready-to-eat fish products (graved/smoked fish) or certain types of unpasteurized cheese. On the contrary, some typically risky foods (e.g. raw milk, red smear cheese, cold seafood) were negatively associated with listeriosis. We offer the following explanations for this finding. Firstly, many of the high-risk foods have become prominent through outbreaks (in other countries) and it is unclear whether outbreak-related risk factors equally apply to sporadic cases (in Germany). Secondly, some high-risk foods (e.g. graved/smoked fish) are characterized by a high prevalence of L. monocytogenes. However, the overall prevalence of L. monocytogenes might not correlate well with the prevalence of pathogenic L. monocytogenes. Frequent occurrence of apathogenic or low virulent strains in retail foods and processing environment has been described [45, 46]. Furthermore, other factors such as food-processing before consumption, the food matrix’s ability to support bacterial growth, and the time between production and consumption of the food may confound the association of a specific food-item with listeriosis.

Our study is subject to potential biases. We enrolled a smaller number of cases than planned which reduced the ability of the study to identify foods associated with listeriosis. Furthermore, cases in this study were somewhat younger and tended to have milder diseases than cases not included in the study and food consumption might depend on age. We aimed to include an age-adjusted representative sample of the German adult population as the reference population in this study, but our controls, as is common for telephone surveys [47], disproportionately contained persons with a high socioeconomic status (SES) (when approximated by educational background). Compared to the German microcensus of 2012, persons with highest educational background were 2-fold over-represented in our control population (33% vs. 16% at microcensus). As consumption of various food items, especially cheese types, was positively correlated with educational background in our large control population (data not shown), these foods were found to be rather negatively than positively correlated with N-PA listeriosis. Although we controlled for the confounding impact of SES analytically in the multivariable model, we cannot exclude that other factors, uncontrolled in this study, relate to consumption patterns through means other than SES.

We did neither enquire about specific types of cold cooked sausages nor about their package and shelf life. Thus, further studies are needed to better characterize the risk associated with this particular food item.


Our study confirmed the outstanding role of reduced immunocompetency for acquiring N-PA listeriosis, and identified ready-to-eat foods as risk factors that are frequently consumed in Germany. These foods usually have an extended shelf-life, are biologically plausible, but have not yet been considered high-risk foods for listeriosis in Germany. To reduce their risk, immunocompromised persons, particularly those receiving immunosuppressive therapy, should consume packaged and pre-sliced cheese (and possibly cold cooked sausages) well before their ‘use-by’ date. It is possible that the microbiological criteria for L. monocytogenes in ready-to-eat foods are inadequate to protect persons with markedly reduced immunocompetency from acquiring listeriosis. Specific recommendations for this population should be formulated or amended and heed the findings of this study.


We thank all study participants and the local and state health authorities for their support. We are grateful to many colleagues in the RKI CATI Call centre, who performed the control interviews, Hannes Ulrich, Constanze Knebel and Elise Curo Gutierrez for study assistance and data entry. We thank Kevin Pollock for language editing of the manuscript.

Author Contributions

Conceived and designed the experiments: AMB KS DW. Performed the experiments: KP. Analyzed the data: KP. Wrote the paper: KP DW. Designed and performed the population-based telephone survey: PS MW. Assisted with epidemiological interpretation: KS DW. Critically revised the manuscript: AMB PS MW KS.


  1. 1. Bavishi C, Dupont HL. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther. 2011;34:1269–81. pmid:21999643
  2. 2. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, et al. Food-related illness and death in the United States. Emerg Infect Dis. 1999;5:607–25. pmid:10511517
  3. 3. Cartwright EJ, Jackson KA, Johnson SD, Graves LM, Silk BJ, Mahon BE. Listeriosis outbreaks and associated food vehicles, United States, 1998–2008. Emerg Infect Dis. 2013;19:1–9. pmid:23260661
  4. 4. Centers for Disease Control and Prevention. Vital signs: Listeria illnesses, deaths, and outbreaks—United States, 2009–2011. MMWR Morb Mortal Wkly Rep. 2013;62:448–52. pmid:23739339
  5. 5. Miettinen MK, Siitonen A, Heiskanen P, Haajanen H, Bjorkroth KJ, Korkeala HJ. Molecular epidemiology of an outbreak of febrile gastroenteritis caused by Listeria monocytogenes in cold-smoked rainbow trout. J Clin Microbiol. 1999;37:2358–60. pmid:10364616
  6. 6. Friesema IH, Kuiling S, van der Ende A, Heck ME, Spanjaard L, van Pelt W. Risk factors for sporadic listeriosis in the Netherlands, 2008 to 2013. Euro Surveill. 2015;20(31). pmid:26290429
  7. 7. Dalton CB, Merritt TD, Unicomb LE, Kirk MD, Stafford RJ, Lalor K, et al. A national case-control study of risk factors for listeriosis in Australia. Epidemiol Infect. 2011;139:437–45. pmid:20429970
  8. 8. Jensen A, Frederiksen W, Gerner-Smidt P. Risk factors for listeriosis in Denmark, 1989–1990. Scand J Infect Dis. 1994;26:171–8. pmid:8036473
  9. 9. Varma JK, Samuel MC, Marcus R, Hoekstra RM, Medus C, Segler S, et al. Listeria monocytogenes Infection from Foods prepared in a Commercial Establishment: A Case-Control Study of Potential Sources of Sporadic Illness in the United States. Clin Infect Dis. 2007;44:521–8. pmid:17243054
  10. 10. Gillespie IA, Mook P, Little CL, Grant K, Adak GK. Listeria monocytogenes infection in the over-60s in England between 2005 and 2008: A retrospective case-control study utilizing market research panel data. Foodborne Pathog Dis. 2010;7:1373–9. pmid:20586610
  11. 11. Werber D, Hille K, Frank C, Dehnert M, Altmann D, Muller-Nordhorn J, et al. Years of potential life lost for six major enteric pathogens, Germany, 2004–2008. Epidemiol Infect. 2013;141:961–8. pmid:22813426
  12. 12. Häder S, Gabler S. [A new sampling design for telephone surveys in Germany.] In: Gabler S, Häder S, Hoffmeyer-Zlotnik JHP, editors. Telefonstichproben in Deutschland. Opladen, Wiesbaden: Westdeutscher Verlag; 1998. p. 69–88.
  13. 13. Lampert T, Kroll LE, Muters S, Stolzenberg H. [Measurement of the socioeconomic status within the German Health Update 2009 (GEDA)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:131–43. pmid:23275948
  14. 14. Bohnsack JF, Brown EJ. The role of the spleen in resistance to infection. Annu Rev Med. 1986;37:49–59. pmid:3518612
  15. 15. de Marie S. Diseases and drug-related interventions affecting host defence. Eur J Clin Microbiol Infect Dis. 1993;12 Suppl 1:S36–41. pmid:8477761
  16. 16. Gan YH. Host susceptibility factors to bacterial infections in type 2 diabetes. PLoS Pathog. 2013;9:e1003794. pmid:24385898
  17. 17. Koscielska-Kasprzak K, Bartoszek D, Myszka M, Zabinska M, Klinger M. The complement cascade and renal disease. Arch Immunol Ther Exp (Warsz). 2014;62:47–57.
  18. 18. Sheth K, Bankey P. The liver as an immune organ. Curr Opin Crit Care. 2001;7:99–104. pmid:11373518
  19. 19. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10:37–48. pmid:9888278
  20. 20. Textor J, Hardt J, Knuppel S. DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology. 2011;22:745. pmid:21811114
  21. 21. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373–9. pmid:8970487
  22. 22. Greenland S, Drescher K. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics. 1993;49:865–72. pmid:8241375
  23. 23. Newson RB. Attributable and unattributable risks and fractions and other scenario comparisons. The Stata Journal. 2013;13:672.
  24. 24. Goulet V, Hebert M, Hedberg C, Laurent E, Vaillant V, De Valk H, et al. Incidence of listeriosis and related mortality among groups at risk of acquiring listeriosis. Clin Infect Dis. 2012;54:652–60. pmid:22157172
  25. 25. Mook P, Jenkins JM, O'Brien SJ, Gillespie IA. Existing medications among non-pregnancy-related listeriosis patients in England, 2007–2009. Epidemiol Infect. 2013;141:36–44. pmid:22404843
  26. 26. Mook P, O'Brien SJ, Gillespie IA. Concurrent conditions and human listeriosis, England, 1999–2009. Emerg Infect Dis. 2011;17:38–43. pmid:21192852
  27. 27. Goulet V, Marchetti P. Listeriosis in 225 non-pregnant patients in 1992: clinical aspects and outcome in relation to predisposing conditions. Scand J Infect Dis. 1996;28:367–74. pmid:8893400
  28. 28. Wenger JD, Swaminathan B, Hayes PS, Green SS, Pratt M, Pinner RW, et al. Listeria monocytogenes contamination of turkey franks: Evaluation of a production facility. J Food Prot. 1990;53:1015–9.
  29. 29. Glass KA, Doyle MP. Fate of Listeria monocytogenes in processed meat products during refrigerated storage. Appl Environ Microbiol. 1989;55:1565–9. pmid:2504110
  30. 30. Pal A, Labuza TP, Diez-Gonzalez F. Safety-based shelf life model for frankfurters based on time to detect Listeria monocytogenes with initial inoculum below detection limit. J Food Prot. 2009;72:1878–84. pmid:19777889
  31. 31. Wallace FM, Call JE, Porto AC, Cocoma GJ, Luchansky JB. Recovery rate of Listeria monocytogenes from commercially prepared frankfurters during extended refrigerated storage. J Food Prot. 2003;66:584–91. pmid:12696680
  32. 32. FDA/FSIS. Quantitative Assessment of Relative Risk to Public Health from Foodborne Listeria monocytogenes Among Selected Categories of Ready-to-Eat Foods. 2003. Food and Drug Administration, United States Department of Agriculture, Centers for Disease Control and Prevention.
  33. 33. Gould LH, Mungai E, Behravesh CB. Outbreaks attributed to cheese: differences between outbreaks caused by unpasteurized and pasteurized dairy products, United States, 1998–2011. Foodborne Pathog Dis. 2014;11:545–51. pmid:24750119
  34. 34. Koch J, Dworak R, Prager R, Becker B, Brockmann S, Wicke A, et al. Large Listeriosis Outbreak Linked to Cheese Made from Pasteurized Milk, Germany, 2006–2007. Foodborne Pathog Dis. 2010;7:1581–4. pmid:20807110
  35. 35. Whitley E, Muir D, Waites WM. The growth of Listeria monocytogenes in cheese packed under a modified atmosphere. J Appl Microbiol. 2000;88:52–7. pmid:10735243
  36. 36. Kousta M, Mataragas M, Skandamis P, Drosinos EH. Prevalence and sources of cheese contamination with pathogens at farm and processing levels. Food Control. 2010;21:805–15.
  37. 37. Bavarian Consumer Organisation. [Market check-up—Shelf-life of pre-sliced cheese at self-service counters.] 2013. Available: Accessed 13 Jan 2015.
  38. 38. Anonymus. Ist die Käsetheke "uncool"? Milch-Marketing. 2013:16–8.
  39. 39. Johansson T, Rantala L, Palmu L, Honkanen-Buzalski T. Occurrence and typing of Listeria monocytogenes strains in retail vacuum-packed fish products and in a production plant. Int J Food Microbiol. 1999;47:111–9. pmid:10357279
  40. 40. Sheen S, Hwang CA. Modeling transfer of Listeria monocytogenes from slicer to deli meat during mechanical slicing. Foodborne Pathog Dis. 2008;5:135–46. pmid:18361687
  41. 41. Little CL, Rhoades JR, Sagoo SK, Harris J, Greenwood M, Mithani V, et al. Microbiological quality of retail cheeses made from raw, thermized or pasteurized milk in the UK. Food Microbiol. 2008;25:304–12. pmid:18206773
  42. 42. Yde M, Naranjo M, Mattheus W, Stragier P, Pochet B, Beulens K, et al. Usefulness of the European Epidemic Intelligence Information System in the management of an outbreak of listeriosis, Belgium, 2011. Euro Surveill. 2012;17(38).
  43. 43. Hartung M, Tenhagen BA, Käsbohrer A. [Zoonotic pathogens in Germany, 2012] Berlin: Federal Institute for Risk Assessment (BfR), 2014. Available: Accessed 6 May 2015.
  44. 44. Walker SJ, Archer P, Banks JG. Growth of Listeria monocytogenes at refrigeration temperatures. J Appl Bacteriol. 1990;68:157–62. pmid:2108109
  45. 45. Norton DM, Scarlett JM, Horton K, Sue D, Thimothe J, Boor KJ, et al. Characterization and pathogenic potential of Listeria monocytogenes isolates from the smoked fish industry. Appl Environ Microbiol. 2001;67:646–53. pmid:11157227
  46. 46. Roche SM, Gracieux P, Albert I, Gouali M, Jacquet C, Martin PM, et al. Experimental validation of low virulence in field strains of Listeria monocytogenes. Infect Immun. 2003;71:3429–36. pmid:12761127
  47. 47. Voigt LF, Koepsell TD, Daling JR. Characteristics of telephone survey respondents according to willingness to participate. Am J Epidemiol. 2003;157:66–73. pmid:12505892
  48. 48. Gomez CR, Boehmer ED, Kovacs EJ. The aging innate immune system. Curr Opin Immunol. 2005;17:457–62. pmid:16084711
  49. 49. Pouillot R, Hoelzer K, Jackson KA, Henao OL, Silk BJ. Relative risk of listeriosis in Foodborne Diseases Active Surveillance Network (FoodNet) sites according to age, pregnancy, and ethnicity. Clin Infect Dis. 2012;54 Suppl 5:S405–10. pmid:22572661
  50. 50. Fuchs J, Busch M, Lange C, Scheidt-Nave C. Prevalence and patterns of morbidity among adults in Germany. Results of the German telephone health interview survey German Health Update (GEDA) 2009. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55:576–86. pmid:22441528
  51. 51. Max Rubner Institute (Ed.). [National Food Consumption Survey II. Report on findings—Part 2], 2008. Available: Accessed 13 Jan 2015.
  52. 52. Jungjohann SM, Luhrmann PM, Bender R, Blettner M, Neuhauser-Berthold M. Eight-year trends in food, energy and macronutrient intake in a sample of elderly German subjects. Br J Nutr. 2005;93:361–78. pmid:15877876
  53. 53. Yeretssian G, Doiron K, Shao W, Leavitt BR, Hayden MR, Nicholson DW, et al. Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection. Proc Natl Acad Sci U S A. 2009;106:9016–20. pmid:19447924
  54. 54. Hulshof KF, Brussaard JH, Kruizinga AG, Telman J, Lowik MR. Socio-economic status, dietary intake and 10 y trends: the Dutch National Food Consumption Survey. Eur J Clin Nutr. 2003;57:128–37. pmid:12548307
  55. 55. Lampert T, Kroll LE, von der Lippe E, Muters S, Stolzenberg H. [Socioeconomic status and health: results of the German Health Interview and Examination Survey for Adults (DEGS1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:814–21. pmid:23703503
  56. 56. Hoffmann F, Glaeske G, Schmiemann G. [Increased prescribing of proton pump inhibitors in ambulatory care over the years 2005–2013]. Z Gastroenterol. 2015;53:95–100. pmid:25251751
  57. 57. Nocon M, Keil T, Willich SN. Prevalence and sociodemographics of reflux symptoms in Germany—results from a national survey. Aliment Pharmacol Ther. 2006;23:1601–5. pmid:16696809
  58. 58. van Boxel OS, Hagenaars MP, Smout AJ, Siersema PD. Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands. Aliment Pharmacol Ther. 2009;29:571–9. pmid:19035978
  59. 59. Schlech WF 3rd, Chase DP, Badley A. A model of food-borne Listeria monocytogenes infection in the Sprague-Dawley rat using gastric inoculation: development and effect of gastric acidity on infective dose. Int J Food Microbiol. 1993;18:15–24. pmid:8466809
  60. 60. Ho JL, Shands KN, Friedland G, Eckind P, Fraser DW. An outbreak of type 4b Listeria monocytogenes infection involving patients from eight Boston hospitals. Arch Intern Med. 1986;146:520–4. pmid:3954524
  61. 61. Ahrens D, Behrens G, Himmel W, Kochen MM, Chenot JF. Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care. Int J Clin Pract. 2012;66:767–73. pmid:22805269